Offer - Urjas Oil for just ₹ 1 X
Trazograf 0.66gm/0.1gm Infusion is a prescription medicine that is available as a Infusion. It is primarily used for the treatment of Diagnostic agent, Diagnostic agent.
The optimal dosage of Trazograf 0.66gm/0.1gm Infusion is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Trazograf 0.66gm/0.1gm Infusion include Nausea or vomiting, Shortness of Breath, Anaphylactic reaction. While these are the most often observed Trazograf 0.66gm/0.1gm Infusion side effects, there are can be others also. These have been listed below. Normally, these side effects of Trazograf 0.66gm/0.1gm Infusion are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Trazograf 0.66gm/0.1gm Infusion has a Moderate effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Trazograf 0.66gm/0.1gm Infusion's effects on the liver, heart and kidney, if any, have been listed below.
Other contraindications of Trazograf 0.66gm/0.1gm Infusion have been discussed in the sections ahead.
Drug reaction of Trazograf 0.66gm/0.1gm Infusion with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Trazograf 0.66gm/0.1gm Infusion, it is important to know that it is not safe while driving, and is not habit-forming.
Trazograf 0.66gm/0.1gm Infusion is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Trazograf 0.66gm/0.1gm Infusion safe for pregnant women?
Trazograf can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Trazograf right away. Take your doctor's advice before taking it again.
Is the use of Trazograf 0.66gm/0.1gm Infusion safe during breastfeeding?
No research work has been carried out till date on effect of Trazograf on breastfeeding women. So it is not known whether taking Trazograf will cause side effects or not.
What is the effect of Trazograf 0.66gm/0.1gm Infusion on the Kidneys?
There can be some harmful effects on your kidneys after taking Trazograf. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Trazograf 0.66gm/0.1gm Infusion on the Liver?
Very few cases of side effects of Trazograf on the liver have been reported.
What is the effect of Trazograf 0.66gm/0.1gm Infusion on the Heart?
You may experience side effects on your heart after taking Trazograf. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Trazograf 0.66gm/0.1gm Infusion unless your doctor advises you to do so -
Is this Trazograf 0.66gm/0.1gm Infusion habit forming or addictive?
No, you will not get addicted to Trazograf 0.66gm/0.1gm Infusion.
Interaction between Food and Trazograf 0.66gm/0.1gm Infusion
Due to a lack of research, nothing can be said about the consequences of taking Trazograf 0.66gm/0.1gm Infusion together with food.
Interaction between Alcohol and Trazograf 0.66gm/0.1gm Infusion
Due to lack of research, there is no information about the side effects of taking Trazograf 0.66gm/0.1gm Infusion with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; MD-76R [Diatrizoate Meglumine and Diatrizoate Sodium Injection]
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; MD-76®R [Diatrizoate Meglumine and Diatrizoate Sodium]